A practical synthesis of the cyclohexyl part of the immunosuppressant FK506

被引:2
作者
Haller, BU [1 ]
Kruber, S [1 ]
Maier, ME [1 ]
机构
[1] Univ Halle Wittenberg, Fachbereich Chem, Inst Organ Chem, D-4010 Halle, Germany
来源
JOURNAL FUR PRAKTISCHE CHEMIE-CHEMIKER-ZEITUNG | 1998年 / 340卷 / 07期
关键词
D O I
10.1002/prac.19983400710
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Starting from the benzylidene lactone 3 of D-(-)-quinic acid the cyclohexyl fragment 15 (C-28-C-34 part) of the immunosuppressant FK506 was synthesized. Key steps include homolytic deoxygenation reactions on compounds 4 and 6 as well as a regioselective opening of the benzylidene acetal 5. Opening of the lactone 7 to provide the methyl ester 8 was followed by methylation of the hydroxy group to give 9. Further steps provided the aldehyde 12 which was elongated to the alkyne 15. This sequence provides 15 in gram quantities.
引用
收藏
页码:656 / 661
页数:6
相关论文
共 31 条
  • [1] STRUCTURE-BASED DESIGN OF AN ACYCLIC LIGAND THAT BRIDGES FKBP12 AND CALCINEURIN
    ANDRUS, MB
    SCHREIBER, SL
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (22) : 10420 - 10421
  • [2] BELSHAW PJ, 1994, SYNLETT, P381
  • [3] BESTMANN HJ, 1980, LIEBIGS ANN CHEM, P2061
  • [4] COREY EJ, 1972, TETRAHEDRON LETT, P3769
  • [5] ENANTIOSELECTIVE SYNTHESIS OF THE C(18)-C(35) SEGMENT OF IMMUNOSUPPRESSANT FK-506 USING EFFICIENT NEW METHODOLOGY
    COREY, EJ
    HUANG, HC
    [J]. TETRAHEDRON LETTERS, 1989, 30 (39) : 5235 - 5238
  • [6] FKBP12-LIGAND-CALCINEURIN INTERACTIONS - ANALOGS OF SBL506
    FURBER, M
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (27) : 7267 - 7268
  • [7] Hanessian S., 1987, Org. Synth, V65, P243
  • [8] SYNTHESIS OF THE 9,10-ACETONIDE OF 9-DIHYDRO-FK-506
    IRELAND, RE
    HIGHSMITH, TK
    GEGNAS, LD
    GLEASON, JL
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (19) : 5071 - 5073
  • [9] A total synthesis of FK-506
    Ireland, RE
    Gleason, JL
    Gegnas, LD
    Highsmith, TK
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (20) : 6856 - 6872
  • [10] IWASAKI K, 1993, DRUG METAB DISPOS, V21, P971